Home LiteratureArticle Details
PMID: 24517367 Published · ppublish English

Design, synthesis and evaluation of 3,4-dihydroxybenzoic acid derivatives as antioxidants, bio-metal chelating agents and acetylcholinesterase inhibitors.

Friggeri Laura, De Vita Daniela, Pandolfi Fabiana, Tortorella Silvano, Costi Roberta, Di Santo Roberto, Scipione Luigi

Abstract

Metal ions, especially copper, zinc and iron, play an important role in the neurodegeneration process because they can affect protein misfolding, leading to the formation of the amyloid deposits and oxidative stress leading to reactive oxygen species (ROS). Here we report the synthesis and evaluation as antioxidant and metal chelating agents of 3,4-dihydroxybenzoic acid derivatives. Synthesized compounds were tested by the 2,2-diphenyl-2-picrylhydrazyl (DPPH) method showing a radical scavenging ability (EC50=0.093-0.118 μM) higher than Trolox used as reference. Furthermore, these compounds were able to bind both iron and copper, especially the iron (III), by the formation of hexa-coordinated complexes. Synthesized compounds were tested to evaluate their ability to inhibit acetyl- and butyryl-cholinesterase; the obtained results have demonstrated that they are selective inhibitors of AChE (Ki=1.5-18.9 μM) and result weakly active versus butyrylcholinesterase (BChE).

Keywords
Antioxidant activity DPPH method Job’s method bio-metal chelation cholinesterase inhibitors
Article Info
Journal
Journal of enzyme inhibition and medicinal chemistry
Abbr.
J Enzyme Inhib Med Chem
Published
2015-09-15
Indexed
2015-01-14
Updated
2016-11-25
Language
English
Country/Region
England
NLM ID
101150203
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]